Ubs Group Ag Lucira Health, Inc. Transaction History

Ubs Group Ag

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$1.27 - $3.39 $41 - $111	-33 Reduced 0.67%	4,877 $5,000
Q2 2022 Aug 10, 2022	BUY	$1.44 - $3.94 $4,739 - $12,966	3,291 Added 203.27%	4,910 $9,000
Q1 2022 May 16, 2022	SELL	$2.86 - $8.83 $437 - $1,350	-153 Reduced 8.63%	1,619 $6,000
Q4 2021 Feb 14, 2022	BUY	$4.94 - $8.94 $3,087 - $5,587	625 Added 54.49%	1,772 $15,000
Q3 2021 Nov 15, 2021	SELL	$6.05 - $10.81 $7,719 - $13,793	-1,276 Reduced 52.66%	1,147 $9,000
Q2 2021 Aug 13, 2021	SELL	$4.56 - $11.45 $2,973 - $7,465	-652 Reduced 21.2%	2,423 $16,000
Q1 2021 May 12, 2021	BUY	$11.65 - $37.0 $35,823 - $113,775	3,075 New	3,075 $37,000

Ticker LHDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,106,500
Market Cap $1.2M
Description
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a paten...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.